NCT01761123View on ClinicalTrials.gov

Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

VXA-A1.1

Trial Locations (1)

Unknown

Scintipharma, Lexington

Sponsors

Lead Sponsor

Vaxart
All Listed Sponsors
lead

Vaxart

INDUSTRY

NCT01761123 - Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum | Biotech Hunter | Biotech Hunter